Kathaleen E Barker, MD | |
3300 Main St, 4th Floor Ste D, Springfield, MA 01107-1112 | |
(413) 794-7045 | |
(413) 794-7345 |
Full Name | Kathaleen E Barker |
---|---|
Gender | Female |
Speciality | Obstetrics/gynecology |
Experience | 15 Years |
Location | 3300 Main St, Springfield, Massachusetts |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1760612600 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207V00000X | Obstetrics & Gynecology | 256869 (Massachusetts) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Baystate Medical Center | Springfield, MA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Baystate Medical Practices Inc | 5991602971 | 1015 |
News Archive
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).
Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.
New research led by a University of Washington biologist demonstrates that there are at least two circadian clocks in the mammal brain, one that sticks strictly to an internal schedule and another that can be altered by external influences such as light and dark.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 3 days ago
Entity Name | Baystate Medical Practices Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1548205909 PECOS PAC ID: 5991602971 Enrollment ID: O20040225000080 |
News Archive
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).
Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.
New research led by a University of Washington biologist demonstrates that there are at least two circadian clocks in the mammal brain, one that sticks strictly to an internal schedule and another that can be altered by external influences such as light and dark.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Kathaleen E Barker, MD 280 Chestnut St, 2nd Floor, Springfield, MA 01199-1001 Ph: (413) 794-5700 | Kathaleen E Barker, MD 3300 Main St, 4th Floor Ste D, Springfield, MA 01107-1112 Ph: (413) 794-7045 |
News Archive
PURE Bioscience, creator of the patented silver dihydrogen citrate (SDC) antimicrobial, today announced that its marketing partner, Richmont Sciences (Richmont), has established distribution of PURE's SDC-based IV-7™ products in the Middle East region. Under this arrangement, PURE sells IV-7 products to Richmont for resale into the Middle East, where the IV-7 water treatment and disinfection products have been registered by the United Arab Emirates-Dubai Municipality. Richmont is initially focusing on distribution of IV-7 Water Treatment™.
Early detection of blood loss to save the lives of soldiers wounded on the battlefield is the goal of a three-year research and development project to be launched this fall at Worcester Polytechnic Institute (WPI). Funded by a $1.9 million grant from the U.S. Army, the research will be conducted in collaboration with the University of Massachusetts Medical School (UMMS).
Inex Pharmaceuticals announced today that United States Food and Drug Administration (FDA) provided an action letter detailing that the anticancer drug Marqibo (vincristine sulfate liposomes injection) is "not approvable" under the FDA's accelerated approval regulations based on the phase 2 clinical trial data submitted.
New research led by a University of Washington biologist demonstrates that there are at least two circadian clocks in the mammal brain, one that sticks strictly to an internal schedule and another that can be altered by external influences such as light and dark.
Although progress has been made in recent years, the matter of youth suicide in Quebec still needs to be more effectively addressed.
› Verified 3 days ago
Ravneet Kaur Thind, DO Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 759 Chestnut St, Springfield, MA 01199 Phone: 413-794-0000 | |
Fadi A Bsat, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 759 Chestnut St, Springfield, MA 01107 Phone: 413-794-9939 | |
Debra A. Disandro, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 3550 Main St Ste 302, Springfield, MA 01107 Phone: 413-781-8290 Fax: 413-737-8540 | |
Dr. Darlene Vargas Maldonado, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3455 Main St Ste C, Springfield, MA 01107 Phone: 413-794-8484 | |
Danielle Nicole Finch, D.O., MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Baystate Medical Ctr, 759 Chestnut St, Springfield, MA 01199 Phone: 413-794-0000 | |
Jean R. Talati, M.D. Obstetrics & Gynecology Medicare: Not Enrolled in Medicare Practice Location: 305 Bicentennial Hwy, Springfield, MA 01118 Phone: 413-733-4101 Fax: 413-796-6821 | |
Dr. David R. Kattan, MD, MPH Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 3300 Main St, 4th Fl, Ste D, Springfield, MA 01107 Phone: 413-794-7045 Fax: 413-794-7345 |